Latest & greatest articles for urinary tract infection

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on urinary tract infection or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on urinary tract infection and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for urinary tract infection

221. Is antimicrobial prophylaxis of urinary tract infections cost effective?

Is antimicrobial prophylaxis of urinary tract infections cost effective? Is antimicrobial prophylaxis of u... preview & related info | Mendeley E-mail address Password ( ) Remember me …or sign in with Search Main Navigation › Short URL Annals of Internal Medicine ( 1981 ) Volume: 94 , Issue: 2 , Pages: 251-255 PubMed: Available from or Find this paper at: Abstract Antimicrobial prophylaxis prevents recurrent urinary tract infections in susceptible women, but its cost effectiveness has not been (...) studied. In a recent placebo-controlled trial of urinary prophylaxis, we also assessed cost effectiveness using a decision analysis model. In our hospital the direct cost of 1 patient year of urinary prophylaxis approximates the cost of treating one episode of cystitis. In women with a baseline infection rate of three per patient year, the annual cost of prophylaxis ($85.82) was less than treatment of acute episodes of infection ($392.30). Sensitivity analyses showed that in women with three

Annals of Internal Medicine1981

222. Single-dose amoxicillin therapy for urinary tract infection. Multicenter trial using antibody-coated bacteria localization technique.

Single-dose amoxicillin therapy for urinary tract infection. Multicenter trial using antibody-coated bacteria localization technique. 6993706 1980 09 28 1980 09 28 2016 10 17 0098-7484 244 6 1980 Aug 08 JAMA JAMA Single-dose amoxicillin therapy for urinary tract infection. Multicenter trial using antibody-coated bacteria localization technique. 561-64 Urine specimens from 134 women with acute, uncomplicated urinary tract infection at three medical centers were examined by the antibody-coated (...) Amoxicillin AIM IM Acute Disease Adolescent Adult Amoxicillin administration & dosage Antibody-Coated Bacteria Test, Urinary Clinical Trials as Topic Cystitis diagnosis drug therapy Female Humans Middle Aged Random Allocation Socioeconomic Factors Urinary Tract Infections diagnosis drug therapy 1980 8 8 1980 8 8 0 1 1980 8 8 0 0 ppublish 6993706

JAMA1980

223. Efficacy of single-dose and conventional amoxicillin therapy in urinary-tract infection localized by the antibody-coated bacteria technic.

Efficacy of single-dose and conventional amoxicillin therapy in urinary-tract infection localized by the antibody-coated bacteria technic. 340949 1978 03 29 1978 03 29 2013 11 21 0028-4793 298 8 1978 Feb 23 The New England journal of medicine N. Engl. J. Med. Efficacy of single-dose and conventional amoxicillin therapy in urinary-tract infection localized by the antibody-coated bacteria technic. 413-6 Urine specimens from 61 women with symptoms of cystitis who are infected with amoxicillin (...) Trial United States N Engl J Med 0255562 0028-4793 0 Antibodies, Bacterial 7C782967RD Ampicillin 804826J2HU Amoxicillin AIM IM Administration, Oral Amoxicillin administration & dosage therapeutic use Ampicillin analogs & derivatives Antibodies, Bacterial analysis Bacterial Infections drug therapy Cystitis diagnosis drug therapy Female Humans Immunologic Techniques Kidney Diseases diagnosis drug therapy Recurrence Urinary Bladder Diseases diagnosis drug therapy Urinary Tract Infections diagnosis drug

NEJM1978

224. Antibiotic irrigation and catheter-associated urinary-tract infections.

Antibiotic irrigation and catheter-associated urinary-tract infections. 210379 1978 10 25 1978 10 25 2010 11 18 0028-4793 299 11 1978 Sep 14 The New England journal of medicine N. Engl. J. Med. Antibiotic irrigation and catheter-associated urinary-tract infections. 570-3 To investigate the efficacy of antibiotic irrigation in preventing catheter-associated urinarytract infection, we carried out a randomized controlled trial of a neomycin-polymyxin irrigant administered through closed urinary (...) albicans isolation & purification Catheters, Indwelling adverse effects Clinical Trials as Topic Drug Resistance, Microbial Enterococcus faecalis isolation & purification Humans Middle Aged Neomycin administration & dosage therapeutic use Polymyxins administration & dosage therapeutic use Prospective Studies Therapeutic Irrigation methods Urinary Catheterization adverse effects Urinary Tract Infections etiology microbiology prevention & control Urine microbiology 1978 9 14 1978 9 14 0 1 1978 9 14 0 0

NEJM1978

225. Trimethoprim-sulfamethoxazole vs ampicillin in chronic urinary tract infections. A double-blind multicenter cooperative controlled study.

Trimethoprim-sulfamethoxazole vs ampicillin in chronic urinary tract infections. A double-blind multicenter cooperative controlled study. 1097747 1975 10 21 1975 10 21 2016 10 17 0098-7484 233 5 1975 Aug 04 JAMA JAMA Trimethoprim-sulfamethoxazole vs ampicillin in chronic urinary tract infections. A double-blind multicenter cooperative controlled study. 427-31 A multicenter, prospective, double-blind, controlled study was performed to compare the efficacy of trimethoprim-sulfamethoxazole (...) with that of ampicillin in the treatment of chronic urinary tract infections. The incidence of adverse clinical signs and symptoms as well as abnormal laboratory values were comparable in the two treatment groups. This study appears to establish the fact that trimethoprim-sulfamethoxazole is an acceptable alternative to ampicillin for the treatment of chronic urinary tract infections caused by susceptible Escherichia coli. Gleckman R A RA eng Clinical Trial Comparative Study Journal Article Randomized Controlled

JAMA1975